Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × atezolizumab × Clear all

NCT04446117 2025-12-18

CONTACT-02

Phase 3 Active not recruiting

575 enrolled 13 charts

Prostatic Neoplasms

NCT02655822 2021-08-30

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Prostatic Neoplasms